Former COVID-vaccine darling announces job cuts a day before quarterly results are set for release. The stock has tumbled more than 70% in the past year as losses have mounted. In a note to employees ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Taking a technology company public is a milestone that brings both opportunity and ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...
Good day. It’s test day for the IPO market. Moderna Inc.’s offering, scheduled to price late today before its Nasdaq debut, will be closely watched as a barometer for the IPO outlook against the ...
Coming into this year, there was a lot of optimism that this would be a strong year for initial public offerings (IPOs), and that optimism has been met — IPOs are back! And, as we’ll show, both the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback